scispace - formally typeset
J

Janneke van’t Hooft

Researcher at Stanford University

Publications -  6
Citations -  230

Janneke van’t Hooft is an academic researcher from Stanford University. The author has contributed to research in topics: Hydroxychloroquine & Clinical trial. The author has an hindex of 3, co-authored 6 publications receiving 98 citations. Previous affiliations of Janneke van’t Hooft include University of Amsterdam.

Papers
More filters
Journal ArticleDOI

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.

Cathrine Axfors, +106 more
TL;DR: In this article, a rapid meta-analysis of ongoing, completed, or discontinued RCTs on hydroxychloroquine or chloroquine treatment for any COVID-19 patients was presented.
Journal ArticleDOI

The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days

TL;DR: The size and speed of the COVID-19 clinical trials agenda is unprecedented, however, most trials were small investigating a small fraction of treatment options, and many trials may end in futility, wasting research resources.
Journal ArticleDOI

Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.

Cathrine Axfors, +106 more
Journal ArticleDOI

Methods used to assess outcome consistency in clinical studies: A literature-based evaluation.

TL;DR: Methods used in evaluation studies of outcome consistency in clinical studies differed considerably, and authors of these studies should refrain from labelling them as “systematic review” and focus on ensuring that the methods used to generate the different outcomes and outcome domains are reported transparently.